No Photo Available

Last Update

2017-03-22T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Lloyd Tillman?

Dr. Lloyd G. Tillman

Direct Phone: (760) ***-****       

Email: l***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Isis Pharmaceuticals , Inc.

2855 Gazelle Court

Carlsbad, California 92010

United States

Company Description

Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners. Isis' broad pipeline consists of 28 drugs to treat a wide variety of diseases with an emphasis on cardiov ... more

Find other employees at this company (559)

Background Information

Employment History

Executive Director Pharm Development

IONIS Education Group

Associate Director, Division Prod Qual Rsch, CDER

Food and Drug Administration

Associate Director, Division Prod Qual Rsch, CDER

Florida Department of Agriculture

Group Leader, Pharm. Development

Burroughs Wellcome Fund

Education

Ph.D.

Web References (10 Total References)


Isis Pharmaceuticals, Inc. - Isis Scientist Awarded 2009 Ebert Prize

ir.isispharm.com [cached]

CARLSBAD, Calif., April 6, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that Lloyd G. Tillman, Ph.D., Executive Director of Pharmaceutical Development of Isis has been awarded the American Pharmacists Association's (APhA) 2009 Ebert Prize. Dr. Tillman received the award at the APhA Annual Meeting and Exposition, April 3-6, 2009, in San Antonio, TX, for work published in the Journal of Pharmaceutical Sciences entitled "Oral Delivery of Antisense Oligonucleotides in Man." His co-authors are Richard S. Geary, Ph.D. and Gregory E. Hardee, Ph.D. (1)

...
I would like to recognize my co-authors, whose advice and hard work contributed significantly to this publication," said Lloyd Tillman. "Our work demonstrated, for the first time, that antisense drugs could be administered orally. The feasibility of oral administration has dramatically broadened the therapeutic and commercial potential of antisense drugs."
The research, which was published in January 2008, provided proof-of-concept for the oral administration of antisense drugs in a single-dose study in man. Scientists at Isis continue to research advances to enhance the pharmaceutical properties of antisense drugs, including oral bioavailability.
"We are pleased that Dr. Tillman was recognized by the APhA to receive this award on our seminal work in advancing the oral delivery of antisense drugs.
...
(1) Lloyd Tillman, Richard S. Geary, Gregory E. Hardee.


Isis: Investors and Media: Press Release

ir.isispharm.com [cached]

Lloyd G. Tillman , Ph.D., Executive Director of Pharmaceutical Development of Isis has been awarded the American Pharmacists Association's (APhA) 2009 Ebert Prize. Dr. Tillman received the award at the APhA Annual Meeting and Exposition, April 3-6, 2009

...
Lloyd Tillman
...
"We are pleased that Dr. Tillman was recognized by the APhA to receive this award on our seminal work in advancing the oral delivery of antisense drugs.
...
Lloyd Tillman


San Diego BioPharma Conference 2009

www.sdbiopharma.org [cached]

Lloyd G. Tillman, Executive Director of Pharmaceutical Development, ISIS Pharmaceuticals


SABPA BioPharmaConf 2009

www.sdbiopharma.org [cached]

Lloyd G. Tillman, Ph.D., Executive Director of Pharmaceutical Development, ISIS Pharmaceuticals, Inc.

...
Lloyd G. Tillman, Executive Director of Pharmaceutical Development, ISIS Pharmaceuticals, Inc.
Dr. Lloyd Tillman is Executive Director of Pharmaceutical Development at Isis Pharmaceuticals, Inc., Carlsbad, CA. He is responsible for formulation research and development of antisense drugs. Beyond enabling new formulations for antisense based therapeutics, he manages development activities for preclinical and clinical supplies and for product registration. While at Isis, he has published several peer-reviewed manuscripts focusing on oligonucleotide formulations. He also lectures courses on Drug Dosage Form Design and Delivery Systems and on Concepts of Pharmacy Practice at the UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences.
Prior to joining Isis in 1997, Dr. Tillman worked at the FDA overseeing the Product Quality Research Laboratory within CDER. His group focused to derive science-based data to support SUPAC and Biopharmaceutics Drug Classification System initiatives and other regulatory guidance's. Previous to the FDA he worked on oral solid dosage forms at Burroughs Wellcome Co. where he managed the pharmaceutical product development of several NCE's into clinical trials and in two cases (MEPRON and VALTREX) into production and onto the market.


Isis: Investors and Media: 2009 Press Releases

ir.isispharm.com [cached]

CARLSBAD, Calif., April 6 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that Lloyd G. Tillman, Ph.D., Executive Director of Pharmaceutical Development of Isis has been awarded the American Pharmacists Association's (APhA) 2009 Ebert Prize. Dr. Tillman received the award at the APhA Annual Meeting and Exposition, April 3-6, 2009, in San Antonio, TX, for work published in the Journal of Pharmaceutical Sciences entitled "Oral Delivery of Antisense Ol...

Similar Profiles

Other People with this Name

Other people with the name Tillman

Vickie Tillman
Morningstar, Inc.

Bonnie Tillman
Kessler Institute for Rehabilitation

Michelle Tillman
SanStone Health

Maile Tillman
UnitedHealthcare

Sandra Tillman
The University of Texas MD Anderson Cancer Center

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory